Celegen’s ozanimod successful in reducing relapse rates

Zeposia is an oral sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Celegen’s ozanimod successful in reducing relapse rates

Post by MSUK » Thu Mar 02, 2017 1:34 am

Positive results from a late-stage clinical trial of ozanimod could make way for another effective multiple sclerosis (MS) treatment...Read more - http://www.ms-uk.org/celegen%E2%80%99s- ... tes-020317
MS-UK - http://www.ms-uk.org/

Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “Zeposia (Ozanimod)”